Events

Adelaide-based Mayne Pharma Group has settled its dispute with generic drug maker Teva Pharmaceuticals over patents covering hormone replacement drug IMVEXXY.

The consumer watchdog has launched proceedings against Kmart for allegedly breaching the Australian Consumer Law by selling cosmetic nail glue without warnings and products with non-compliant button batteries.

An appeals court has found US drug maker Cosette could not rely on sales performance figures to justify its termination of a $672 million merger agreement with Mayne Pharma Group. 

Insurer IAG has argued Greensill investor White Oak failed to verify the existence of $140 million in receivables for fear the deal wouldn't go ahead -- conduct, it says, that was “redolent of a deal that is too good to be true”. 

Trading platform Plus500 has taken its challenge to an investor class action to the High Court, after an appeals court upheld a finding that an arbitration clause in its terms and conditions was unfair.

Animal health giant Abbey Laboratories has fought off a challenge to its bid to register 'Virkill' as a trade mark for its disinfectant products, despite an IP Australia delegate finding the name was deceptively similar to its opponent's 'Virukill' mark.

A judge has extended interim confidentiality orders in a Fair Work lawsuit against Atlassian, but lifted an injunction barring the tech company from performance managing the employee. 

The managing director of stockbroking firm Fortrend Securities breached privacy rules by sending an adviser's medical certificate to a client and saying he had a “nervous breakdown”, a tribunal has found. 

A judge has held that the former environment minister's finding that part of the McPhillamy's gold mine was heritage protected was invalid. 

A judge said Tuesday a costs referee’s report did not give an “adequate basis” for $13 million in fees sought by a law firm behind a settled class action against Qantas over COVID-era flight cancellations.